| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 70.36▲ | 70.39▲ | 70.35▲ | 70.26▲ | 71.23▼ |
| MA10 | 70.28▲ | 70.34▲ | 69.97▲ | 70.26▲ | 74.84▼ |
| MA20 | 70.31▲ | 70.02▲ | 69.93▲ | 70.92▼ | 81.22▼ |
| MA50 | 70.27▲ | 70.03▲ | 70.37▲ | 75.82▼ | 95.96▼ |
| MA100 | 70.00▲ | 70.14▲ | 70.72▲ | 81.43▼ | 115.67▼ |
| MA200 | 69.92▲ | 70.80▲ | 71.93▼ | 89.89▼ | 97.14▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.033▲ | 0.088▲ | 0.125▲ | 0.343▲ | -0.333▼ |
| RSI | 68.525▲ | 59.204▲ | 57.688▲ | 45.165▼ | 32.697▼ |
| STOCH | 61.364 | 84.359▲ | 82.759▲ | 61.170 | 12.115▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -33.459 | -79.611▼ |
| CCI | 356.863▲ | 129.094▲ | 163.230▲ | 9.018 | -86.591 |
|
Monday, November 10, 2025 05:23 AM
Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic T-cell infiltration and reducing immunosuppressive ...
|
|
Thursday, November 06, 2025 05:14 AM
Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal second ...
|
|
Thursday, November 06, 2025 04:57 AM
Third Avenue Management, an investment management company based in New York City, released its “Third Avenue Small-Cap Value Fund” third-quarter 2025 investor letter. A copy of the letter can be ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/25 | 70.255 | 70.91 | 70.255 | 70.91 | 6,667 |
| 12/11/25 | 69.43 | 70.91 | 68.73 | 70.28 | 423,900 |
| 11/11/25 | 70.30 | 71.99 | 69.31 | 69.63 | 404,200 |
| 10/11/25 | 70.58 | 70.58 | 68.76 | 69.83 | 443,503 |
| 07/11/25 | 70.49 | 71.92 | 69.78 | 70.64 | 438,200 |
| 06/11/25 | 70.75 | 71.195 | 70.12 | 70.73 | 398,146 |
| 05/11/25 | 71.41 | 72.89 | 70.66 | 71.38 | 502,099 |
| 04/11/25 | 71.99 | 73.28 | 67.9225 | 70.41 | 1,061,197 |
| 03/11/25 | 69.75 | 70.267 | 65.62 | 68.34 | 905,900 |
| 31/10/25 | 71.65 | 71.65 | 69.11 | 70.49 | 470,400 |
|
|
||||
|
|
||||
|
|